skip to content

Faculty of Economics

Media Mentions & Appearances | Published on Thursday, 7 April, 2022

Dr. Flavio Toxvaerd was interviewed by Sebastian Galiani, for his 'Conversations' video series (in Spanish).

In the Conversations with Sebastian Galiani: Episode XLV, Dr Toxvaerd spoke about his research into Economy and Epidemiology, Vaccine markets and contagious diseases.

Media Mentions & Appearances | Published on Wednesday, 15 December, 2021

Dr. Flavio Toxvaerd has commented on Sky News about a study which shows COVID certification led more people to get vaccinated.

He said the study "confirms that people respond to incentives, in this case incentives to get vaccinated, and requiring vaccine certification makes life for the unvaccinated more cumbersome".

Media Mentions & Appearances | Published on Wednesday, 24 November, 2021

Dr. Flavio Toxvaerd participated in a panel event for the Economics Observatory, "A one-two punch: health and economics".

Dr. Toxvaerd, along with Melanie Cockroft (Intensive Care Senior Clinical Fellow), Paula Lorgelly (UCL) and Ben Moll (LSE) were in conversation with Chris Giles (Financial Times).

Media Mentions & Appearances | Published on Wednesday, 10 November, 2021

Watch videos from the Modelling Behaviour to Inform Policy for Pandemics event, that Dr. Flavio Toxvaerd and Newton Gateway to Mathematics organised.

Media Mentions & Appearances | Published on Thursday, 28 October, 2021

Dr. Flavio Toxvaerd chaired The Great Vaccine Rollout: Covid-19, Cooperation & Global Public Goods webinar, organised by The Bennett Institute for Public Policy.

Media Mentions & Appearances | Published on Monday, 4 October, 2021

Dr. Flavio Toxvaerd explains how economics can be used to inform public health policy in a new podcast recorded by the London School of Economics.

Media Mentions & Appearances | Published on Wednesday, 29 September, 2021

Dr. Flavio Toxvaerd has published a new Economics Observatory article which looks at, post COVID-19, how our attitudes have changed towards spending time with people we don't know as opposed to our close family and friends.

Media Mentions & Appearances | Published on Thursday, 23 September, 2021

Dr. Flavio Toxvaerd was quoted in an article for the daily Russian newspaper Izvestia, that looks at the inequality of the worldwide distribution of the COVID-19 vaccine.

Media Mentions & Appearances | Published on Monday, 20 September, 2021

Dr. Flavio Toxvaerd was interviewed for The Wall Street Journal on how the vaccine roll out and Delta variant are effecting the global recovery.

Media Mentions & Appearances | Published on Friday, 20 August, 2021

In this Economics Observatory article, Dr. Flavio Toxvaerd explains that international cooperation of vaccine rollout is crucial, and asks how well are we doing?

Media Mentions & Appearances | Published on Tuesday, 17 August, 2021

Dr. Flavio Toxvaerd explains in the Economics Observatory, vaccines should be valued higher than treatments, because with communicable diseases they reduce the likelihood of people becoming seriously ill.

Economics News | Published on Thursday, 17 June, 2021

A world-wide pandemic could have started at any point in the past century since Spanish Flu circled the globe. However, as Dr Toxvaerd explains; “To a certain extent the world ‘got lucky’, and the world was almost lulled into a false sense of security; it was thought we could contain a virus as well as we did SARS. This turned out to be wrong.”

Media Mentions & Appearances | Published on Wednesday, 16 June, 2021

Dr. Flavio Toxvaerd spoke to the BBC World Service about vaccine apathy and the hesitation amongst some members of the public to get vaccinated. Dr. Toxvaerd says that "vaccine hesitancy has always existed, but it has never really come to the fore as much as it has been in recent times" - (the external article is in French).

Media Mentions & Appearances | Published on Monday, 14 June, 2021

Dr. Flavio Toxvaerd has contributed to a piece on vaccines for the first edition of the Economics Observatory's ECO Magazine. In the article Dr. Toxvaerd and Tony Yates look at how vaccine nationalism is driving countries to compete for doses.

Media Mentions & Appearances | Published on Monday, 7 June, 2021

Dr. Flavio Toxvaerd was interviewed for the BBC News on the proposed easing of UK restrictions in June. Given the COVID-19 variants and the rising number of new cases, Dr. Toxvaerd gave his thoughts on whether the Government should stick to the hard date of the 21st June for removing all restrictions in the UK.

Media Mentions & Appearances | Published on Friday, 4 June, 2021

Dr. Flavio Toxvaerd was interviewed for National Danish Radio’s Orientation programme about the impending easing of restrictions in the U.K. Even before the current restrictions have been lifted, there is already fear of a third wave in the UK.

Media Mentions & Appearances | Published on Tuesday, 25 May, 2021

Dr. Flavio Toxvaerd was interviewed by The Telegraph about public confidence in the vaccine roll out and the use of PCR test kits. The article suggests that people are less inclined than a month ago to take up offer of a COVID-19 test.

Media Mentions & Appearances | Published on Monday, 24 May, 2021

Dr. Flavio Toxvaerd was interviewed by BBC Scotland News for their COVID-19 Special. The programme consisted of live coverage of the Scottish Government’s Briefing, with reaction and expert analysis. Dr.

Media Mentions & Appearances | Published on Friday, 14 May, 2021

Dr. Flavio Toxvaerd has written a new article for the Economics Observatory that looks at whether the patents on Covid-19 vaccines should be waived to allow low-income countries to produce their own doses. There has been much debate about this and if such a course of action is likely to have any effect.

Media Mentions & Appearances | Published on Thursday, 13 May, 2021

Dr. Flavio Toxvaerd and Anthony McDonnell (Center for Global Development), have written a new article for the Economics Observatory that discusses the inequalities of vaccine development. This blog looks at how lower-income countries are often left out of the race to develop and distribute vaccines.

Media Mentions & Appearances | Published on Tuesday, 11 May, 2021

Dr. Flavio Toxvaerd was interviewed for the At The Margin Podcast about The Economics of Vaccines. Among other topics, Dr.

Media Mentions & Appearances | Published on Tuesday, 4 May, 2021

Dr. Flavio Toxvaerd and Tony Yates (independent economist), have written a new article for the Economics Observatory that discusses ‘vaccine nationalism’.

Media Mentions & Appearances | Published on Sunday, 2 May, 2021

Dr. Flavio Toxvaerd was interviewed for the Russian newspaper Izvestia about the increase in world wide COVID-19 cases. The article also looks at the catastrophic situation in India and the recent coronavirus outbreaks in other Asian countries.

Economics News | Published on Tuesday, 27 April, 2021

“Now that the rollout of vaccinations across many nations is well underway, our research has found that many people are starting to change the way they behave,” says Dr Flavio Toxvaerd.

Media Mentions & Appearances | Published on Thursday, 25 March, 2021

Dr. Flavio Toxvaerd was quoted in an article for NBC News, where he spoke about the effect possible trade restrictions could have on international distribution of COVID-19 vaccines and on new variants.

Media Mentions & Appearances | Published on Thursday, 28 January, 2021

Dr. Flavio Toxvaerd was interviewed for BBC World Service's Marketplace Morning Report programme, where he spoke about the distribution of COVID-19 vaccines to the European Union.

Economics News | Published on Tuesday, 24 November, 2020

“It’s great news we have two possible vaccines against COVID-19 that are likely to start rolling out soon, and a third in the wings,” says Dr Flavio Toxvaerd. “Many people are focussed on the benefit from the inoculation.

Media Mentions & Appearances | Published on Tuesday, 24 November, 2020

Flavio Toxvaerd and Miltos Makris (University of Kent) have published an article for VOXeu titled "Vaccines against COVID-19 are on the horizon; now is the time to manage the transition rationally".